依卡替班成功治疗获得性C1抑制剂缺乏症。 - Suppr

Successful treatment of acquired C1 inhibitor deficiency with icatibant.

作者信息

Bright P, Dempster J, Longhurst H

出版信息

Clin Exp Dermatol. 2010 Jul;35(5):553-4. doi: 10.1111/j.1365-2230.2010.03788.x. Epub 2010 Mar 12.

DOI:10.1111/j.1365-2230.2010.03788.x

PMID:20337653

Abstract

摘要

相似文献

Successful treatment of acquired C1 inhibitor deficiency with icatibant.

Clin Exp Dermatol. 2010 Jul;35(5):553-4. doi: 10.1111/j.1365-2230.2010.03788.x. Epub 2010 Mar 12.

Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.

Prescrire Int. 2010 Nov;19(110):245-7.

[Allergy-immunology. New therapies for acute attacks in hereditary angioedema].

Rev Med Suisse. 2011 Jan 19;7(278):103-5.

Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):380-382. doi: 10.1016/j.anai.2017.07.032. Epub 2017 Aug 31.

Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema.

Emerg Med J. 2011 Aug;28(8):720-1. doi: 10.1136/emermed-2011-200396-4.

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.

Allergy. 2012 Aug;67(8):1074-7. doi: 10.1111/j.1398-9995.2012.02853.x. Epub 2012 Jun 12.

Rapid resolution of erythema marginatum after icatibant in acquired angioedema.

Acta Derm Venereol. 2011 Mar;91(2):185-6. doi: 10.2340/00015555-1055.

Insurers will find icatibant lifesaving but expensive treatment. Managed care once again faces the all-too-familiar debate about cost and benefit.

Manag Care. 2011 Nov;20(11):63-4.

Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

J Dtsch Dermatol Ges. 2010 Apr;8(4):272-4. doi: 10.1111/j.1610-0387.2009.07215.x. Epub 2009 Sep 16.

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9.

引用本文的文献

Icatibant in the treatment of Angiotensin-converting enzyme inhibitor-induced angioedema.

Case Rep Crit Care. 2014;2014:864815. doi: 10.1155/2014/864815. Epub 2014 Sep 23.

Hereditary angioedema: epidemiology, management, and role of icatibant.

Biologics. 2013;7:103-13. doi: 10.2147/BTT.S27566. Epub 2013 May 3.

In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.

Clin Exp Immunol. 2013 Jul;173(1):1-7. doi: 10.1111/cei.12083.

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Core Evid. 2012;7:105-14. doi: 10.2147/CE.S24743. Epub 2012 Sep 27.

Management of acute attacks of hereditary angioedema: potential role of icatibant.

Vasc Health Risk Manag. 2010 Sep 7;6:795-802. doi: 10.2147/vhrm.s4332.

HAE international home therapy consensus document.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):22. doi: 10.1186/1710-1492-6-22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment of acquired C1 inhibitor deficiency with icatibant.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献